Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.

Henrich, Martin T; Oertel, Wolfgang H; Surmeier, D James; Geibl, Fanni F

Henrich, Martin T; Oertel, Wolfgang H; Surmeier, D James; Geibl, Fanni F.

Afiliação

Henrich MT; Department of Psychiatry and Psychotherapy, Philipps University Marburg, 35039, Marburg, Germany.
Oertel WH; Department of Neurology, Philipps University Marburg, 35043, Marburg, Germany.
Surmeier DJ; Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
Geibl FF; Department of Neurology, Philipps University Marburg, 35043, Marburg, Germany.

Mol Neurodegener ; 18(1): 83, 2023 Nov 11.

Article em En | MEDLINE | ID: mdl-37951933

Assuntos

Doença de Parkinson; Humanos; Doença de Parkinson/metabolismo; Estresse Oxidativo; Mitocôndrias/metabolismo; Antioxidantes/uso terapêutico; Antioxidantes/metabolismo

Palavras-chave

Antioxidants; Electron transport chain; MPTP; Mitochondria; Mitochondrial dysfunction; Neuroprotective therapies; Parkinson's disease; Synuclein

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Parkinson Limite: Humans Idioma: En Revista: Mol Neurodegener Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google